Daily Bulletin

Men's Weekly

.

Chinese NMPA Accepts New Drug Application for Illuccix for Prostate Cancer Imaging

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Chinese NMPA Accepts New Drug Application for Illuccix for Prostate Cancer Imaging

MELBOURNE, Australia and INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has accepted the filing of a New Drug Application (NDA) for TLX591-Px (Illuccix®, Kit for the...

Read more: Chinese NMPA Accepts New Drug Application for Illuccix for Prostate Cancer Imaging

Business News

How Thorough Component Inspections Protect Your Supply Chain from Costly Failures

In the modern world, where manufacturing has become highly interconnected, the weakest components of the supply chain can only make the chain as strong as it is. One defective component might cause ...

Daily Bulletin - avatar Daily Bulletin

3PL Logistics in Australia: Strengthening Supply Chains for Growing Businesses

Australia’s vast geography and diverse consumer markets make logistics a critical part of business success. As companies scale and customer expectations rise, many turn to 3pl logistics australia to...

Daily Bulletin - avatar Daily Bulletin

Why Choosing The Right Shopify Web Developer Shapes Long-Term Ecommerce Success

Building a Shopify store that performs reliably over time requires more than surface-level setup. Working with an experienced Shopify web developer ensures that the platform is configured with inten...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business